My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.375 -0.125 (-3.57%)

Streaming Delayed Price Updated: 10:17 AM EDT, Apr 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 Next >

Maravai Lifesciences (NASDAQ:MRVI) Returns to Positive Adjusted EBITDA and Issues 2026 Guidance ↗

February 25, 2026

Via Chartmill

Top movers in Wednesday's after hours session ↗

February 25, 2026

Via Chartmill

Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet ↗

February 06, 2026

This medical device firm supplies hospitals worldwide with single-use products for critical care, surgery, and interventional procedures.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About a New $9 Million Bet on an Energy Distributor Stock ↗

February 06, 2026

This energy sector distributor delivers maintenance, repair, and supply chain solutions to industrial clients across a global network.

Via The Motley Fool

Topics Economy Regulatory Compliance

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

What to Expect from Maravai LifeSciences's Earnings ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Insights Ahead: Maravai LifeSciences's Quarterly Earnings ↗

May 09, 2025

Via Benzinga

This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit ↗

February 06, 2026

Arcutis Biotherapeutics develops topical therapies for chronic skin conditions, with a portfolio targeting psoriasis and atopic dermatitis.

Via The Motley Fool

Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗

November 06, 2025

Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations.

Via Chartmill

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....

Via MarketMinute

Topics Economy Stocks

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

4 Analysts Have This To Say About Maravai LifeSciences ↗

December 05, 2024

Via Benzinga

Decoding 5 Analyst Evaluations For Maravai LifeSciences ↗

November 08, 2024

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results ↗

May 13, 2025

Via Benzinga

Assessing Maravai LifeSciences: Insights From 5 Financial Analysts ↗

May 13, 2025

Via Benzinga

Breaking Down Maravai LifeSciences: 4 Analysts Share Their Views ↗

March 25, 2025

Via Benzinga

Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday ↗

March 25, 2025

Via Benzinga

Topics Government

Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript ↗

March 21, 2025

MRVI earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Maravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

October 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 20, 2025

Via Benzinga

3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk ↗

March 16, 2025

Via The Motley Fool

Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings ↗

January 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 08, 2024

Via Benzinga

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday ↗

November 08, 2024

Via Benzinga

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

November 08, 2024

Via Benzinga

Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript ↗

November 08, 2024

MRVI earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.